The State University of Campinas, commonly called Unicamp, is a public research university in the state of São Paulo, Brazil. Unicamp is consistently ranked among the top universities in Brazil and Latin America.

During the past decade, Universidade Estadual De Campinas conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universidade Estadual De Campinas" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "University of Campinas, Brazil" with 4 trials sponsored, "FHI 360" with 2 trials sponsored, "Ionis Pharmaceuticals, Inc." with 2 trials sponsored and "ANS Pharma" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidade Estadual De Campinas" #1 collaborator was "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 2 trials as a collaborator, "ANS Pharma" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Universidade Estadual De Campinas" are "Multiple Myeloma" (3 trials), "Contraception" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Acute B-Cell Lymphoblastic Leukaemia" (1 trials) and "Antibiotics" (1 trials). Many other conditions were trialed in "Universidade Estadual De Campinas" in a lesser frequency.

Most popular intervention types in "Universidade Estadual De Campinas" are "Drug" (16 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dexamethasone" (2 trials), "Diacerein" (2 trials), "Eplontersen" (2 trials) and "ALX1-11" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidade Estadual De Campinas" are 16 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Universidade Estadual De Campinas". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Universidade Estadual De Campinas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universidade Estadual De Campinas, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Universidade Estadual De Campinas has several departments that took part in Clinical trials: "Piracicaba Dental School, State University of Campinas" - 22 trials